A recent study by Wollert et al. provides additional insight, demonstrating that patients presenting with acute myocardial infarction and elevated plasma GDF15 levels benefited more from an aggressive interventional approach compared to patients with lower levels of this cytokine [27]. This evidence concerns the gene GDF15 and myocardial infarction.